The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake

  • Pritchett C
  • Pardee A
  • McGuirk S
 et al. 
  • 15

    Readers

    Mendeley users who have this article in their library.
  • 11

    Citations

    Citations of this article.

Abstract

Nucleus accumbens μ-opioid stimulation leads to robust increases in the intake of highly palatable foods, such as a high-fat diet. While interactions between opioids and certain striatal neurotransmitters underlying this phenomenon have been explored, many potential interactions have not. Striatal adenosine has been shown to have a significant influence on striatal neurotransmission and locomotor activity behavior, however the interaction between opioids and adenosine on feeding behaviors has received less attention. The present study explored this interaction within the context of opioid-driven consumption of a high-fat diet. Specifically, intra-accumbens administration of selective A1 and A2Aadenosine receptor ligands, with or without concurrent administration of the μ-opioid agonistD-Ala2,N,Me-Phe4,Gly-ol5-enkaphalin (DAMGO), on high-fat consumption and associated locomotor activity was examined. The A1 receptor agonist 2-Chloro-N6-cyclopentyladenosine (CCPA) had no effect on either baseline or DAMGO-induced locomotor or consumption behaviors associated with the high-fat diet. However, the A2Areceptor agonist 2-p-(2 carboxyethyl)-phenethylamino-5′-N-ethylcarboxamido adenosine hydrochloride (CGS 21680) and the prodrug of the A2Areceptor antagonist MSX-2, 3-(3-hydroxypropyl)-8-(m-methoxystyryl)-7-methyl-1-propargylxanthine phosphate disodium salt (MSX-3) produced the expected decrease and increase in locomotor activity, respectively. CGS 21680 had no effect on baseline or DAMGO-driven consumption of the high-fat diet. MSX-3 had no effect on DAMGO-induced locomotor activity but increased DAMGO-induced consumption. Lastly, the increased activity and consumption produced by MSX-3 alone was blocked by prior administration of the opioid antagonist naltrexone. In summary, these results suggest a potential role of striatal adenosine A2Areceptors in mediating baseline and striatal opioid-mediated intake of a high-fat diet. © 2009 Elsevier B.V. All rights reserved.

Author-supplied keywords

  • Adenosine
  • CCPA
  • CGS 21680
  • DAMGO
  • Feeding
  • High fat
  • MSX-3
  • Nucleus accumbens
  • Palatable food

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Carolyn E. Pritchett

  • Alicia L. Pardee

  • Sophia R. McGuirk

  • Matthew J. Will

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free